Literature DB >> 28697148

Consideration of Clinical Context and Alternative Therapies in Aggressive Resuscitation for Prevention of Post-ERCP Pancreatitis.

Anna E Phillips1, Georgios I Papachristou2,3, Adam Slivka1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 28697148      PMCID： PMC5762431          DOI： 10.1097/MCG.0000000000000875

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  5 in total

1.  Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data.

Authors:  B Joseph Elmunzer; Peter D R Higgins; Sameer D Saini; James M Scheiman; Robert A Parker; Amitabh Chak; Joseph Romagnuolo; Patrick Mosler; Rodney A Hayward; Grace H Elta; Sheryl J Korsnes; Suzette E Schmidt; Stuart Sherman; Glen A Lehman; Evan L Fogel
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

2.  Aggressive Hydration With Lactated Ringer Solution in Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-analysis of Randomized Controlled Trials.

Authors:  Zhi-Feng Zhang; Zhi-Jun Duan; Li-Xia Wang; Gang Zhao; Wu-Guo Deng
Journal:  J Clin Gastroenterol       Date:  2017-03       Impact factor: 3.062

3.  A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.

Authors:  B Joseph Elmunzer; James M Scheiman; Glen A Lehman; Amitabh Chak; Patrick Mosler; Peter D R Higgins; Rodney A Hayward; Joseph Romagnuolo; Grace H Elta; Stuart Sherman; Akbar K Waljee; Aparna Repaka; Matthew R Atkinson; Gregory A Cote; Richard S Kwon; Lee McHenry; Cyrus R Piraka; Erik J Wamsteker; James L Watkins; Sheryl J Korsnes; Suzette E Schmidt; Sarah M Turner; Sylvia Nicholson; Evan L Fogel
Journal:  N Engl J Med       Date:  2012-04-12       Impact factor: 91.245

Review 4.  Incidence, risk factors, and prevention of post-ERCP pancreatitis.

Authors:  Scott T Cooper; Adam Slivka
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

5.  Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.

Authors:  B Joseph Elmunzer; Jose Serrano; Amitabh Chak; Steven A Edmundowicz; Georgios I Papachristou; James M Scheiman; Vikesh K Singh; Shyam Varadurajulu; John J Vargo; Field F Willingham; Todd H Baron; Gregory A Coté; Joseph Romagnuolo; April Wood-Williams; Emily K Depue; Rebecca L Spitzer; Cathie Spino; Lydia D Foster; Valerie Durkalski
Journal:  Trials       Date:  2016-03-03       Impact factor: 2.279
  5 in total
  2 in total

Review 1.  Aggressive Hydration With Ringer's Lactate in the Prevention of Post-ERCP Pancreatitis: A Meta-Analysis.

Authors:  Samar Aljohani; Hyder Mirghani
Journal:  Cureus       Date:  2021-05-07

2.  Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.

Authors:  Xavier J N M Smeets; David W da Costa; Paul Fockens; Chris J J Mulder; Robin Timmer; Wietske Kievit; Marieke Zegers; Marco J Bruno; Marc G H Besselink; Frank P Vleggaar; Rene W M van der Hulst; Alexander C Poen; Gerbrand D N Heine; Niels G Venneman; Jeroen J Kolkman; Lubbertus C Baak; Tessa E H Römkens; Sven M van Dijk; Nora D L Hallensleben; Wim van de Vrie; Tom C J Seerden; Adriaan C I T L Tan; Annet M C J Voorburg; Jan-Werner Poley; Ben J Witteman; Abha Bhalla; Muhammed Hadithi; Willem J Thijs; Matthijs P Schwartz; Jan Maarten Vrolijk; Robert C Verdonk; Foke van Delft; Yolande Keulemans; Harry van Goor; Joost P H Drenth; Erwin J M van Geenen
Journal:  Trials       Date:  2018-04-02       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.